IGS1 fundamentals
An in-depth look to IGC PHARMA INC. DL -,01 operating, investing, and financing activities
IGS1 free cash flow for Q3 23 is -1.5 M EUR. For 2022, IGS1 free cash flow was -6.79 M EUR and operating cash flow was -6.5 M EUR.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM